Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

U.S. Senators: Bipartisan proposal to lower drug prices

Senate Finance Committee Chairman and Republican Chuck Grassley and the panel’s leading Democrat, Senator Ron Wyden, announced a bipartisan proposal to lower the Rx drug prices.

Read More »

U.S. appeals court signals sympathy to bid to strike down Obamacare

A federal appeals court panel expressed skepticism to Democratic calls to overturn the ruling of a Texas judge who found the landmark U.S. healthcare reform law unconstitutional.

Read More »

U.S. states accuse 20 drugmakers of price fixing

U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc. of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices – sometimes by more than 1,000 percent – and stifle competition for generic drugs, state prosecutors said.

Read More »

Powerful Senate committee invites pharma executives to testify

A powerful U.S. Senate committee invited seven pharmaceutical companies to testify at a hearing during February 2019 examining rising prescription drug prices.

Read More »

U.S. lawmakers request info from insulin makers on rising prices

Two powerful U.S. lawmakers sent letters to the three leading insulin manufacturers requesting information on why its cost has skyrocketed in recent years and how much the companies profit from the life-sustaining diabetes treatment.

Read More »

Senate Finance Committee and House Oversight Committee Take Aim at Drug Pricing

The U.S. Senate Finance Committee and the House Oversight Committee started hearings focused on high drug prices.

Read More »

Sen. Sanders, Rep. Cummings to introduce bill to lower U.S. drug prices

U.S. Senator Bernie Sanders and Representative Elijah Cummings plan to introduce legislation aimed at lowering the cost of prescription drugs for U.S. consumers.

Read More »

New York City launches $100 million universal health insurance program

New York City launched a $100 million health insurance program to cover 600,000 uninsured residents, including those unable to afford coverage and those living in the United States illegally.

Read More »

Stocks fall as judge rules Obamacare unconstitutional

Shares of U.S. health insurers, hospitals, and healthcare companies fell after a federal judge ruled that Barack Obama’s signature healthcare law was unconstitutional.

Read More »

Republican pricing projects could hit industry bottom line

Prices, profits and promotional spend are closely linked. Reduce prices and promotion will plummet. But wait, the Republicans are in control. Accordingly, pharma, its marketing partners and even Wall Street often rest easy, especially when Republicans control Congress and the White House.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom